Exercise of Warrants

Summary by AI BETAClose X

MedPal AI plc received notice to exercise warrants over 1,570,000 ordinary shares at an exercise price of 2.5 pence per share, raising £39,250; the Warrant Shares are expected to be admitted to trading on AIM around 9 November 2026 and will rank pari passu with existing shares. Following Admission the issued share capital will be 891,519,135 ordinary shares, meaning the issuance increases the share count by 1.57 million, representing approximately 0.176% dilution. The transaction delivers a small cash injection while leaving voting rights and capital structure effectively unchanged beyond the updated total voting rights denominator.

Disclaimer*

UK 100

Latest directors dealings